FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Keppra (levetiracetam) submitted by UCB, Inc., authorizing changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures
• Seizure Disorders

Drugs mentioned

• Keppra (levetiracetam)

Snippet

SUPPL AP for KEPPRA (LEVETIRACETAM)